Legg Mason Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,000
Closed -$387K 128
2018
Q3
$387K Sell
5,000
-300
-6% -$22.7K 0.36% 106
2018
Q2
$376K Sell
5,300
-200
-4% -$14.1K 0.3% 114
2018
Q1
$415K Sell
5,500
-100
-2% -$7.95K 0.29% 113
2017
Q4
$402K Sell
5,600
-700
-11% -$53.2K 0.24% 120
2017
Q3
$511K Sell
6,300
-200
-3% -$15.3K 0.3% 110
2017
Q2
$461K Sell
6,500
-400
-6% -$26.6K 0.38% 112
2017
Q1
$469K Sell
6,900
-400
-5% -$28.1K 0.54% 84
2016
Q4
$523K Sell
7,300
-1,300
-15% -$96.6K 0.6% 79
2016
Q3
$681K Hold
8,600
0.69% 78
2016
Q2
$718K Sell
8,600
-200
-2% -$17.7K 0.77% 57
2016
Q1
$809K Hold
8,800
0.83% 52
2015
Q4
$891K Sell
8,800
-400
-4% -$41.6K 0.93% 39
2015
Q3
$904K Sell
9,200
-400
-4% -$44.4K 0.91% 41
2015
Q2
$1.12M Buy
9,600
+3,000
+45% +$328K 1.02% 22
2015
Q1
$648K Sell
6,600
-900
-12% -$91.4K 0.53% 95
2014
Q4
$707K Buy
+7,500
New +$776K 0.53% 83

Other funds holding GILD

Legg Mason Asset Management's GILD Position: Q4 2018 in Review

Legg Mason Asset Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 5,000 shares — an estimated $387K sold.

Legg Mason Asset Management first reported a position in GILD in Q4 2014 and held it in 16 quarters. The position peaked at $1.12M in Q2 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

  • Legg Mason Asset Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
  • Legg Mason Asset Management sold 5,000 Gilead Sciences shares in Q4 2018, an estimated $387K.
  • Legg Mason Asset Management first reported a position in Gilead Sciences in Q4 2014 and held it in 16 quarters.
  • Legg Mason Asset Management's Gilead Sciences position peaked at $1.12M in Q2 2015.
  • 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Legg Mason Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.